Study #2021-0694
TAME: A pilot study of weekly paclitaxel, bevacizumab, and Tumor Associated Macrophage targeted therapy (zoledronic acid) in women with recurrent, platinum-resistant, Epithelial ovarian, fallopian tube or primary peritoneal cancer
MD Anderson Study Status
Not Accepting
Treatment Agent
Paclitaxel/Bev (control), Paclitaxel/Bev + ZA (experimental)
Description
This is a randomized pilot trial of weekly paclitaxel and bevacizumab with or without zoledronic acid in women with platinum-resistant epithelial ovarian cancer with 1-2 prior regimens for recurrence.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Epithelial Ovarian, Fallopian Tube, Primary Peritoneal Cancer
Study phase:
Phase I (Early)
Physician name:
Shannon Westin
Department:
Gynecologic Oncology & Reproductive Medicine
For general questions about clinical trials:
1-844-338-0349
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.